Evidence map›Paper›PMID 32125626›Full record

ArticleJournal of molecular neuroscience : MN2020

Mutations in GAA Gene in Tunisian Families with Infantile Onset Pompe Disease: Novel Mutation and Structural Modeling Investigations.

Olfa Alila-Fersi, Hajer Aloulou, Ines Werteni, Nadia Mahfoudh, Imen Chabchoub, Hassen Kammoun, Leila Keskes, Mongia Hachicha, Neila Belguith, Faiza Fakhfakh

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Olfa Alila-FersiMolecular Genetics and functional Laboratory, Faculty of Science of Sfax, University of Sfax, Route Soukra Km2.5, 3000, Sfax, Tunisia. alilafersiolfa@yahoo.fr.ORCID http://orcid.org/0000-0001-6558-3997
Hajer AloulouDepartment of Pediatrics, Hédi Chaker Hospital, 3029, Sfax, Tunisia.
Ines WerteniDepartment of Pediatrics, Rabta hospital, Tunis, Tunisia.
Nadia MahfoudhDepartment of Immunology, Hedi Chaker Hospital, 3029, Sfax, Tunisia.
Imen ChabchoubDepartment of Pediatrics, Hédi Chaker Hospital, 3029, Sfax, Tunisia.
Hassen KammounHuman Molecular Genetics Laboratory, Faculty of Medecine of Sfax, University of Sfax, Sfax, Tunisia.
Leila KeskesHuman Molecular Genetics Laboratory, Faculty of Medecine of Sfax, University of Sfax, Sfax, Tunisia.
Mongia HachichaDepartment of Pediatrics, Hédi Chaker Hospital, 3029, Sfax, Tunisia.
Neila BelguithDepartment of medical Genetics, Hédi Chaker Hospital, 3029, Sfax, Tunisia.
Faiza FakhfakhMolecular Genetics and functional Laboratory, Faculty of Science of Sfax, University of Sfax, Route Soukra Km2.5, 3000, Sfax, Tunisia. faiza.fakhfakh02@gmail.com.
Hopital Universitaire Hedi Chaker · TNUniversity of Sfax · TNHôpital La Rabta · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pompe disease, a rare, autosomal, recessive, inherited, lysosomal storage disorder, is caused by mutations in the acid α-glucosidase (GAA) gene leading to a deficiency of the lysosomal GAA enzyme. Some GAA mutations eliminate all enzymatic activities, causing severe infantile Pompe disease; others allow residual GAA activity and lead to middle adulthood forms. Here, we report a cohort of 12 patients, belonging to 11 unrelated families, with infantile Pompe disease. The mutational analysis of GAA gene revealed a novel c.1494G > A (p.Trp498X) mutation in one patient and three known mutatio,ns including the c.1497G > A (p.Trp499X) mutation, in two patients, the c.1927G > A (p.Gly643Arg) mutation in one patient and the common c.236_246del (p.Pro79ArgfsX13) mutation in eight patients. The high prevalence of c.236_246del mutation in our cohort (58%) was supported by the existence of a common founder ancestor that was confirmed by its segregation of similar SNPs haplotype, including four intragenic SNPs of GAA gene. In addition, a 3D structure model and a docking were generated for the mutant p.Gly643Arg using the crystal structure of human GAA as template and the 4-methylumbelliferyl-α-D-glucopyranoside as substrate. The results showed that the arginine at position 643 caused electrostatic changes in neighboring regions, leading to the repulsion between the amino acids located in the catalytic cavity of the GAA enzyme, thus restricting access to its substrate. These structural defects could cause the impairment of the transport and maturation previously reported for p.Gly643Arg mutation.

Indexed as

Mutationalpha-GlucosidasesCatalytic DomainFemaleGlucosidesGlycogen Storage Disease Type IIHumansHymecromoneInfantMaleMolecular Docking SimulationProtein Binding4-methylumbelliferyl glucosidealpha-GlucosidasesGAA protein, humanGlucosidesHymecromone3D structureFounder mutationGAA geneInfantile Pompe diseaseNovel mutation

Identifiers

PMID32125626
OpenAlexW3010546172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.